AAAAAA

   
Results: 1-16 |
Results: 16
Chronic hepatitis C in HIV-coinfected patients: Feasibility and efficacy of interferon-alpha 2b and ribavirin combination therapy
Authors: Nasti, G di Gennaro, G Rizzardini, G Cadorin, L Tirelli, U
Citation: G. Nasti et al., Chronic hepatitis C in HIV-coinfected patients: Feasibility and efficacy of interferon-alpha 2b and ribavirin combination therapy, J ACQ IMM D, 26(3), 2001, pp. 299-300
Discordant HHV8 detection in a young HIV-negative patient with Kaposi's sarcoma and sarcoidosis
Authors: di Gennaro, G Canzonieri, V Schioppa, O Nasti, G Carbone, A Tirelli, U
Citation: G. Di Gennaro et al., Discordant HHV8 detection in a young HIV-negative patient with Kaposi's sarcoma and sarcoidosis, CLIN INF D, 32(7), 2001, pp. 1100-1102
Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin
Authors: Nasti, G Di Gennaro, G Tavio, M Cadorin, L Tedeschi, RM Talamini, R Carbone, A Tirelli, U
Citation: G. Nasti et al., Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin, AIDS, 15(14), 2001, pp. 1783-1787
Human immunodeficiency virus-related non-Hodgkin lymphoma - Activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients
Authors: Spina, M Vaccher, E Juzbasic, S Milan, I Nasti, G Talamini, R Fasan, M Antinori, A Nigra, E Tirelli, U
Citation: M. Spina et al., Human immunodeficiency virus-related non-Hodgkin lymphoma - Activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients, CANCER, 92(1), 2001, pp. 200-206
Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma
Authors: Vaccher, E Spina, M di Gennaro, G Talamini, R Nasti, G Schioppa, O Vultaggio, G Tirelli, U
Citation: E. Vaccher et al., Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma, CANCER, 91(1), 2001, pp. 155-163
Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma
Authors: Vaccher, E Spina, M di Gennaro, G Talamini, R Nasti, G Schioppa, O Vultaggio, G Tirelli, U
Citation: E. Vaccher et al., Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma, CANC CYTOP, 91(1), 2001, pp. 155-163
Effects of 2-year antiretroviral combination therapies on HIV-1 DNA levels
Authors: Zanussi, S Bortolin, MT Tirelli, U Nasti, G Vaccher, E Giacca, M De Paoli, P
Citation: S. Zanussi et al., Effects of 2-year antiretroviral combination therapies on HIV-1 DNA levels, J ACQ IMM D, 23(5), 2000, pp. 439-441
Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: Results of a phase II study
Authors: Nasti, G Errante, D Talamini, R Rizzardini, G Fasan, M Landonio, G Zeroli, C Chichino, G Nigra, E Vaccher, E Tirelli, U
Citation: G. Nasti et al., Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: Results of a phase II study, J CL ONCOL, 18(7), 2000, pp. 1550-1557
Human immunodeficiency virus-associated Hodgkin's disease
Authors: Spina, M Vaccher, E Nasti, G Tirelli, U
Citation: M. Spina et al., Human immunodeficiency virus-associated Hodgkin's disease, SEMIN ONCOL, 27(4), 2000, pp. 480-488
Effects of therapy with highly active anti-retroviral therapy (HAART) and IL-2 on CD4(+) and CD8(+) lymphocyte apoptosis in HIV+ patients
Authors: Caggiari, L Zanussi, S Bortolin, MT D'Andrea, M Nasti, G Simonelli, C Tirelli, U De Paoli, P
Citation: L. Caggiari et al., Effects of therapy with highly active anti-retroviral therapy (HAART) and IL-2 on CD4(+) and CD8(+) lymphocyte apoptosis in HIV+ patients, CLIN EXP IM, 120(1), 2000, pp. 101-106
HAART is effective as anti-Kaposi's sarcoma therapy only after remission has been induced by chemotherapy
Authors: Vaccher, E di Gennaro, G Nasti, G Juzbasic, S Tirelli, U
Citation: E. Vaccher et al., HAART is effective as anti-Kaposi's sarcoma therapy only after remission has been induced by chemotherapy, J ACQ IMM D, 22(4), 1999, pp. 407-408
AIDS-associated Kaposi's sarcoma is more aggressive in women: A study of 54 patients
Authors: Nasti, G Serraino, D Ridolfo, A Antinori, A Rizzardini, G Zeroli, C Nigro, L Tavio, M Vaccher, E Tirelli, U
Citation: G. Nasti et al., AIDS-associated Kaposi's sarcoma is more aggressive in women: A study of 54 patients, J ACQ IMM D, 20(4), 1999, pp. 337-341
Combination therapy with alpha interferon and lamivudine in patients with chronic hepatitis B and HIV infection
Authors: Nasti, G di Gennaro, G Donada, C Donadon, V Tirelli, U
Citation: G. Nasti et al., Combination therapy with alpha interferon and lamivudine in patients with chronic hepatitis B and HIV infection, AIDS, 13(15), 1999, pp. 2176-2178
A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma. (vol 20, pg 403, 1999)
Authors: Nasti, G Errante, D Santarossa, S Vaccher, E Tirelli, U
Citation: G. Nasti et al., A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma. (vol 20, pg 403, 1999), DRUG SAFETY, 20(6), 1999, pp. 473-473
A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma
Authors: Nasti, G Errante, D Santarossa, S Vaccher, E Tirelli, U
Citation: G. Nasti et al., A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma, DRUG SAFETY, 20(5), 1999, pp. 403-425
Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART+IL-2
Authors: Zanussi, S Simonelli, C Bortolin, MT D'Andrea, M Crepaldi, C Vaccher, E Nasti, G Politi, D Barzan, L Tirelli, U De Paoli, P
Citation: S. Zanussi et al., Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART+IL-2, CLIN EXP IM, 116(3), 1999, pp. 486-492
Risultati: 1-16 |